TruaceTracing the truth around AIFriday, August 28, 2026
The Index

What the evidence says.What the public feels.

Ranks distinct AI gain and problem claims from the published record. Scores reward impact, independent source strength, scale, confidence, and recency.

1,182 results
Show filters and sorting

AI gains · 658

68
GainHealth· Stable· Evidence: Moderate (1 source)

Advances in AI have enabled opportunistic identification of osteoporosis and other pathologies on imaging performed for other indications.

This opinion article examines the concept of clinical justification for osteoporosis imaging, noting that advances in imaging and AI now permit opportunistic identification of osteoporosis and other conditions beyond the original scan purpose, and discusses how these opportunistic tools might eventually become standalone justified diagnostic pathways.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%94

Updated Jul 30, 2026 · TRV-2026-0589

68
GainHealth· Stable· Evidence: Moderate (1 source)

In a retrospective audit of 5,000 women, the LBC-NET pipeline detected HSIL+ with higher sensitivity than senior cytopathologists and reduced review time while increasing daily capacity.

Researchers audited 5,000 archived liquid-based cytology cases and compared an interpretable machine learning pipeline, LBC-NET, to a double-blind panel of senior cytopathologists for detection of high-grade squamous intraepithelial lesions or worse, testing robustness across age and clinical subgroups.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%94

Updated Jul 30, 2026 · TRV-2026-0588

68
GainScience· Stable· Evidence: Moderate (1 source)

Release of SynTabFall synthetic dataset with 745,380 samples allows training fall-risk prediction models without original patient data while achieving performance on par with models trained on real data.

On 2026-07-24, researchers described SynTabFall, a synthetic tabular health dataset of 745,380 samples and 44 attributes covering demographics, diseases, mobility and cognition risk factors for fall risk assessment. They reported that models trained on the synthetic data can reach predictive performance on par with models trained on real data, without requiring access to original patient records.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%94

Updated Jul 29, 2026 · TRV-2026-0583

68
GainHealth· Stable· Evidence: Moderate (1 source)

AI and ML improved pharmaceutical research and healthcare capacity by enabling large-scale biomedical data analysis and data-driven decision-making.

By July 2026, a narrative review of 127 peer-reviewed studies from 2015-2026 examined how AI and ML are being used in pharmaceutical research and healthcare. The review found the technologies enable large-scale biomedical data analysis and data-driven decision-making while simultaneously introducing interconnected ethical challenges.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%94

Updated Jul 27, 2026 · TRV-2026-0578

AI problems · 524

68
ProblemPolicy· Stable· Evidence: Moderate (1 source)

Existing AI development remains monocultural and top-down, with gaps in inclusion and persistent power asymmetries and epistemic justice concerns.

On 2026-07-02, a peer-reviewed paper in AI & SOCIETY introduced Value-Sensitive Citizen Science (VSCS), a framework that combines Value-Sensitive Design with citizen science to involve community members as co-researchers in AI development. It uses the Participatory Value-Cognition Taxonomy and extended scenario reasoning to translate local values into technical requirements and embeds governance for lifecycle oversight.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%92

Updated Jul 17, 2026 · TRV-2026-0253

68
ProblemScience· Stable· Evidence: Moderate (1 source)

Machine learning models for biomolecular recognition do not inherently enforce thermodynamic consistency and may produce configurations that are not physically realizable.

Published July 17, 2026, this perspective argues that quantitative prediction of biomolecular recognition requires moving beyond static structures to ensemble-based thermodynamic and kinetic observables. It reviews physics-based sampling under approximate Hamiltonians and modern machine learning models that learn from structural and bioactivity data.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%92

Updated Jul 17, 2026 · TRV-2026-0244

68
ProblemScience· Stable· Evidence: Moderate (1 source)

MLFFs still face challenges in computational efficiency and scale, accuracy and generalization, data requirements, interpretability, and physical constraints when applied to inorganic crystalline materials.

On 2026-07-17, a review in Physical Chemistry Chemical Physics summarized machine learning force fields for inorganic crystalline materials, describing how they combine first-principles accuracy with classical force-field efficiency to enable atomic-level studies across structural prediction, physical properties, defects and interfaces, and phase transitions.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%92

Updated Jul 17, 2026 · TRV-2026-0243

68
ProblemScience· Stable· Evidence: Moderate (1 source)

Existing literature on AI-human decision-making was fragmented and lacked integrative frameworks to explain how AI-human dynamics and decision typologies shape outcomes despite increasingly intricate human-AI interplay.

On 2026-04-03, a peer-reviewed article reported a systematic review and bibliometric analysis of 627 articles on human-AI decision-making. The authors identified two critical dimensions, AI-human dynamics and decision typologies, and proposed a novel conceptual framework comprising four paradigms: adaptive intuitive, programmed algorithmic, interpretive analytical, and integrative hybrid decision-making.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%92

Updated Jul 15, 2026 · TRV-2026-0226

Recomputed live from the record · Aug 28, 2026, 7:47 AM